MULTI-001 Nivolumab v6 MULTI-018 Larotrectinib v1
RCC-008 Lenvatinib (Kisplyx®) & Everolimus (Afinitor®) v1 RCC-009 Tivozanib v1 RCC-010 Ipilimumab in combination with Nivolumab for RCC v1 RCC-011 Avelumab and axitinib v1
